2021-07-16
Cost-Effectiveness of Alpelisib for Advanced Breast Cancer in a Dutch Setting
Publication
Publication
| Additional Metadata | |
|---|---|
| Luyendijk, M. | |
| hdl.handle.net/2105/62507 | |
| Master Health Economics, Policy and Law | |
| Organisation | Erasmus School of Health Policy & Management |
|
Misrielal, A. (2021, July 16). Cost-Effectiveness of Alpelisib for Advanced Breast Cancer in a Dutch Setting. Master Health Economics, Policy and Law. Retrieved from http://hdl.handle.net/2105/62507 |
|